Waycross Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$416K Hold
1,700
0.04% 55
2025
Q4
$352K Hold
1,700
0.03% 81
2025
Q3
$315K Hold
1,700
0.03% 87
2025
Q2
$260K Hold
1,700
0.02% 90
2025
Q1
$282K Hold
1,700
0.03% 60
2024
Q4
$246K Hold
1,700
0.03% 62
2024
Q3
$276K Hold
1,700
0.04% 62
2024
Q2
$248K Hold
1,700
0.04% 69
2024
Q1
$269K Hold
1,700
0.05% 67
2023
Q4
$266K Hold
1,700
0.05% 77
2023
Q3
$265K Hold
1,700
0.06% 87
2023
Q2
$281K Hold
1,700
0.06% 92
2023
Q1
$264K Hold
1,700
0.08% 85
2022
Q4
$300K Hold
1,700
0.11% 81
2022
Q3
$278K Hold
1,700
0.19% 85
2022
Q2
$302K Hold
1,700
0.2% 77
2022
Q1
$301K Hold
1,700
0.18% 78
2021
Q4
$291K Hold
1,700
0.17% 83
2021
Q3
$275K Hold
1,700
0.17% 86
2021
Q2
$280K Hold
1,700
0.15% 73
2021
Q1
$279K Hold
1,700
0.16% 83
2020
Q4
$268K Buy
+1,700
New +$251K 0.17% 76

Other funds holding JNJ

Waycross Partners's JNJ Position: Q1 2026 in Review

Waycross Partners held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 1,700 shares worth $416K. The position accounts for 0.04% of the portfolio, ranked #55.

Waycross Partners first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Waycross Partners held 1,700 shares of Johnson & Johnson worth $416K as of Q1 2026.
  • Waycross Partners left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.04% of Waycross Partners's portfolio in Q1 2026, its #55 holding.
  • Waycross Partners first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Waycross Partners's 13F filing for Q1 2026, filed 7 May 2026.